silodosin 4 MG Oral Capsule

1 INDICATIONS AND USAGE Silodosin, a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies (14 ) ] . Silodosin capsules are not indicated for the treatment of hypertension. Silodosin, an alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Silodosin capsules are not indicated for the treatment of hypertension. ( 1 )

Amneal Pharmaceuticals NY LLC

FDA Reported Adverse Reactions
`[1] fatigue` `[2] off label use` `[3] drug ineffective` `[4] nausea` `[5] pain` `[6] headache` `[7] dyspnoea` `[8] toxicity to various agents` `[9] diarrhoea` `[10] arthralgia`

4 years ago

CAPSULE WHITE AN 1421

16 HOW SUPPLIED/STORAGE AND HANDLING

SILODOSIN capsules, 4 mg are supplied as white, opaque, hard # 3 gelatin capsules imprinted with “AN” in gold on the cap and “1421” in gold on the body. They are available as follows: Bottles of 30: NDC 69238-1421-3 Bottles of 90: NDC 69238-1421-9

SILODOSIN capsules, 8 mg are supplied as white, opaque, hard # l gelatin capsules imprinted with “AN” in green on the cap and “1420” in green on the body. They are available as follows: Bottles of 30: NDC 69238-1420-3 Bottles of 90: NDC 69238-1420-9 Storage Store at 20° to 25ºC (68° to 77ºF); excursions permitted between 15º to 30ºC (59° to 86ºF) [see USP Controlled Room Temperature]. Protect from light and moisture. Keep out of reach of children.

More pills like CAPSULE AN 1421

Related Pills

silodosin 8 MG Oral Capsule

Amneal Pharmaceuticals NY LLC

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site